EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The KEAP1-NRF2 System and Neurodegenerative Diseases

Akira Uruno iD, Masayuki Yamamoto

Antioxidants & Redox Signaling · 2023-05 · 38 (13-15) · 974-988

DOI: 10.1089/ars.2023.0234 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 03.05.2023. Verfasst von Akira Uruno und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, NF-E2-Related Factor 2. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 139 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Significance: Central nervous system (CNS) diseases are disorders of the brain and/or spinal cord and include neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Nuclear factor erythroid 2–related factor 2 (NRF2) is a transcription factor belonging to the cap-n-collar family that harbors a unique basic leucine zipper motif and plays as a master regulator of homeostatic responses. Recent Advances: Kelch-like ECH-associated protein 1 (KEAP1) is an adaptor of the Cullin3 (CUL3)-based ubiquitin E3 ligase that enhances the ubiquitylation of NRF2, which promotes the degradation of NRF2 to suppress its transcriptional activity in the absence of stress. Cysteine residues of KEAP1 are modified under stress conditions, and NRF2 degradation is attenuated, allowing it to accumulate and induce the expression of target genes. This regulatory system is referred to as the KEAP1-NRF2 system and plays a central role in protecting cells against various stresses. NRF2 also negatively regulates the expression of inflammatory cytokine and chemokine genes and suppresses pathological inflammation. As oxidative stress, inflammation, and proteostasis are known to contribute to neurodegenerative diseases, the KEAP1-NRF2 system is an attractive target for the treatment of these diseases. Critical Issues: In mouse models of neurodegenerative diseases, Nrf2 depletion exacerbates symptoms and enhances oxidative damage and inflammation in the CNS. In contrast, chemical or genetic NRF2 activation improves these symptoms. Indeed, the NRF2-activating chemical dimethyl fumarate is now widely used for the clinical treatment of MS. Future Directions: The KEAP1-NRF2 system is a promising therapeutic target for neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesNF-E2-Related Factor 2AnimalsHumansInflammationKelch-Like ECH-Associated Protein 1Oxidative StressUbiquitin-Protein Ligases

Stichwörter der Autor:innen

Alzheimer's diseaseKEAP1NRF2Parkinson's diseasemultiple sclerosisneurodegenerative disease

Substanzen

Keap1 protein, mouseKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Ubiquitin-Protein LigasesNFE2L2 protein, human

Autor:innen und Institutionen

  • Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
  • Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.

ORCID-Profile: Akira Uruno

Zitieren

APA

Uruno, A., & Yamamoto, M. (2023). The KEAP1-NRF2 System and Neurodegenerative Diseases. Antioxidants & Redox Signaling, 38(13-15), 974-988. https://doi.org/10.1089/ars.2023.0234

Vancouver

Uruno A, Yamamoto M. The KEAP1-NRF2 System and Neurodegenerative Diseases. Antioxidants & Redox Signaling. 2023;38(13-15):974-988. doi:10.1089/ars.2023.0234

BibTeX
@article{Uruno2023,
  author = {Uruno, Akira and Yamamoto, Masayuki},
  title = {The KEAP1-NRF2 System and Neurodegenerative Diseases},
  journal = {Antioxidants & Redox Signaling},
  year = {2023},
  volume = {38},
  number = {13-15},
  pages = {974--988},
  doi = {10.1089/ars.2023.0234}
}
Kostenlos starten →